The biorepository will enable researchers at the hospital to access tissue samples from across the institution. Rush and Tempus will also work together to develop 3-D organoids to test how patients may respond to specific cancer treatments.
“The collaboration we are announcing today should allow us over a very short period of time to collect thousands of bio-specimens that will be used to fuel decades of groundbreaking research,” said Dr. Ranga Krishnan, senior vice president of Rush.
The agreement builds on Rush and Tempus’ existing collaboration, under which Tempus provides the hospital with molecular sequencing and analysis for cancer patients.
More articles on health IT:
Allscripts partners with Conversa for clinical conversation platform
Congressional App Challenge names director
Kalorama: Physician frustration drives regular EMR vendor switching
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
